Cycling without CDK2?
- 31 August 2003
- journal article
- editorial
- Published by Elsevier BV in Trends in Cell Biology
- Vol. 13 (8), 396-399
- https://doi.org/10.1016/s0962-8924(03)00148-x
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Review of flavopiridol, a cyclin-dependent kinase inhibitor, as breast cancer therapySeminars in Oncology, 2002
- Small molecule modulators of cyclin-dependent kinases for cancer therapyOncogene, 2000
- Cancer Cell CyclesScience, 1996
- E2F-1 accumulation bypasses a G1 arrest resulting from the inhibition of G1 cyclin-dependent kinase activity.Genes & Development, 1995
- Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16Nature, 1995
- Principles of CDK regulationNature, 1995
- Cyclins and cancer II: Cyclin D and CDK inhibitors come of ageCell, 1994
- Negative regulation of the growth-promoting transcription factor E2F-1 by a stably bound cyclin A-dependent protein kinaseCell, 1994
- Distinct Roles for Cyclin-Dependent Kinases in Cell Cycle ControlScience, 1993
- Regulation of the cell cycle by the cdk2 protein kinase in cultured human fibroblasts.The Journal of cell biology, 1993